|
1
|
European Centre for Disease Prevention and
Control. https://www.ecdc.europa.eu/en/publications-data/hantavirus-infection-annual-epidemiological-report-2020.
Accessed June 9, 2023.
|
|
2
|
Zeier M, Handermann M, Bahr U, Rensch B,
Müller S, Kehm R, Muranyi W and Darai G: New ecological aspects of
hantavirus infection: A change of a paradigm and a challenge of
prevention-a review. Virus Genes. 30:157–180. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Avšič-Županc T, Saksida A and Korva M:
Hantavirus infections. Clin Microbiol Infect. 21S:e6–e16.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lupuşoru G, Lupuşoru M, Ailincăi I, Bernea
L, Berechet A, Spătaru R and Ismail G: Hanta hemorrhagic fever with
renal syndrome: A pathology in whose diagnosis kidney biopsy plays
a major role (review). Exp Ther Med. 22(984)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Muia J, Gao W, Haberichter SL, Dolatshahi
L, Zhu J, Westfield LA, Covill SC, Friedman KD and Sadler JE: An
optimized fluorogenic ADAMTS13 assay with increased sensitivity for
the investigation of patients with thrombotic thrombocytopenic
purpura. J Thromb Haemost. 11:1511–1518. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Brocklebank V, Wood KM and Kavanagh D:
Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol.
13:300–317. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hauglustaine D, Van Damme B, Vanrenterghem
Y and Michielsen P: Recurrent hemolytic uremic syndrome during oral
contraception. Clin Nephrol. 15:148–153. 1981.PubMed/NCBI
|
|
8
|
Hauglustaine D, Vanrenterghem Y,
Michielsen OP and van Damme B: Oestrogen containing oral
contraceptives, decreased prostacyclin production, and haemolytic
uraemic syndrome. Lancet. 1:328–329. 1981.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shirai H, Yashima J, Tojimbara T and Honda
K: Thrombotic microangiopathy caused by oral contraceptives in a
kidney transplant recipient. Nephrology. 21:41–43. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
van Regenmortel MHV, Fauquet CM, Bishop
DHL, Carsten EB, Estes MK, Lemon SM, Maniloff J, Mayo MA, McGeoch
DJ, Pringle CR and Wickner RB: Virus Taxonomy: Seventh Report of
the International Committee on Taxonomy of Viruses, 1st edition.
Academic Press, San Diego, CA, pp35-38, 2000.
|
|
11
|
Lee HW, Lee PW and Johnson KM: Isolation
of the etiologic agent of Korean hemorrhagic fever. J Infect Dis.
190:298–308. 1978.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Avsic-Zupanc T, Petrovec M, Furlan P, Kaps
R, Elgh F and Lundkvist A: Hemorrhagic fever with renal syndrome in
the Dolenjska region of Slovenia-a 10-year survey. Clin Infect Dis.
28:860–865. 1999.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Steer A: Pathogenesis of renal changes in
epidemic hemorrhagic fever. In: The Kidney IAP Monograph. Mostofi
FK and Smith DE (eds). Williams & Wilkins, Baltimore, MD,
pp476-486, 1996.
|
|
14
|
Jokinen EJ and Lähdevirta JCY:
Nephropathiaepidemica: Immunohistochemical study of pathogenesis.
Clin Nephrol. 9:1–5. 1978.PubMed/NCBI
|
|
15
|
Zaki SR, Greer PW, Coffield LM, Goldsmith
CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan
AS, et al: Hantavirus pulmonary syndrome. Pathogenesis of an
emerging infectious disease. Am J Pathol. 146:552–579.
1995.PubMed/NCBI
|
|
16
|
Kim S, Kang ET, Kim YG, Han JS, Lee JS,
Kim JI, Hall WC, Dalrymple JM and Peters CJ: Localization of
Hantaan viral envelope glycoproteins by monoclonal antibodies in
renal tissues from patients with Korean hemorrhagic fever H. Am J
Clin Pathol. 100:398–403. 1993.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Groen J, Bruijn JA, Gerding MN, Jordans
JG, Moll van Charante AW and Osterhaus AD: Hantavirus antigen
detection in kidney biopsies from patients with nephropathia
epidemica. Clin Nephrol. 46:379–383. 1996.PubMed/NCBI
|
|
18
|
Poljak M and Avsic Zupanc T:
Immunohistochemical detection of Hantaan virus antigen in renal
tissue from patient with hemorrhagic fever with renal syndrome.
Nephron. 67(252)1994.PubMed/NCBI View Article : Google Scholar
|
|
19
|
European Centre for Disease Prevention and
Control: Hantavirus infection-Annual epidemiological report for
2018. https://www.ecdc.europa.eu/en/publications-data/hantavirus-infection-annual-epidemiological-report-20182020.
Accessed January 25, 2022).
|
|
20
|
National Institute for Public Health: INSP
Report for 2018. https://www.insp.gov.ro/index.php/informatii-publice/send/7-informatii-publice/722-raport-insp-2018.
Accessed 25 January 25, 2022).
|
|
21
|
Douron E, Moriniere B, Matheron S, Girard
PM, Gonzalez JP, Hirsch F and McCormick JB: HFRS after a wild
rodent bite in the Haute-Savoie-and risk of exposure to
Hantaan-like virus in a Paris laboratory. Lancet. 1:676–677.
1984.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gavrilovskaya IN, Brown EJ, Ginsberg MH
and Mackow ER: Cellular entry of hantaviruses which cause
hemorrhagic fever with renal syndrome is mediated by beta3
integrins. J Virol. 73:3951–3959. 1999.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Peebles RS Jr and Graham BS: Viruses,
dendritic cells and the lung. Respir Res. 2:245–249.
2001.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Schönrich G, Rang A, Lütteke N, Raftery
MJ, Charbonnel N and Ulrich RG: Hantavirus-induced immunity in
rodent reservoirs and humans. Immunol Rev. 225:163–189.
2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Saksida A, Wraber B and Avšič-Županc T:
Serum levels of inflammatory and regulatory cytokines in patients
with hemorrhagic fever with renal syndrome. BMC Infect Dis.
11(142)2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hägele S, Müller A, Nusshag C, Reiser J,
Zeier M and Krautkrämer E: Motility of human renal cells is
disturbed by infection with pathogenic hantaviruses. BMC Infect
Dis. 18(645)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
McCAUGHEY C and Hart CA: Hantaviruses. J
Med Microbiol. 49:587–599. 2000.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Linderholm M and Elgh F: Clinical
characteristics of hantavirus infections on the Eurasian continent.
Curr Top Microbiol Immunol. 256:135–151. 2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Krüger DH, Ulrich R and Lundkvist AA:
Hantavirus infections and their prevention. Microbes Infect.
3:1129–1144. 2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gavrilovskaya IN, Gorbunova EE and Mackow
ER: Pathogenic hantaviruses direct the adherence of quiescent
platelets to infected endothelial cells. J Virol. 84:4832–4839.
2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Laine O, Mäkelä S, Mustonen J, Huhtala H,
Szanto T, Vaheri A, Lassila R and Joutsi-Korhonen L: Enhanced
thrombin formation and fibrinolysis during acute Puumala hantavirus
infection. Thromb Res. 126:154–158. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang M, Wang J, Wang T, Li J, Hui L and Ha
X: Thrombocytopenia as a predictor of severe acute kidney injury in
patients with Hantaan virus infections. PLoS One.
8(e53236)2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Rasche FM, Uhel B, Krüger DH, Karges W,
Czock D, Hampl W, Keller F, Meisel H and von Müller L:
Thrombocytopenia and acute renal failure in Puumala hantavirus
infections. Emerg Infect Dis. 10:420–425. 2004.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Paakkala A, Mustonen J, Viander M, Huhtala
H and Pasternack A: Complement activation in nephropathia epidemica
caused by Puumala hantavirus. Clin Nephrol. 53:424–431.
2000.PubMed/NCBI
|
|
35
|
Sane J, Laine O, Mäkelä S, Paakkala A,
Jarva H, Mustonen J, Vapalahti O, Meri S and Vaheri A: Complement
activation in Puumala hantavirus infection correlates with disease
severity. Ann Med. 44:468–475. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Vaheri A, Henttonen H, Voutilainen L,
Mustonen J, Sironen T and Vapalahti O: Hantavirus infections in
Europe and their impact on public health. Rev Med Virol. 23:35–49.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
37
|
Stojanovic M, Pekic S, Cvijovic G, Miljic
D, Doknic M, Nikolic-Djurovic M, Micic D, Hrvacevic R, Nesic V and
Popovic V: High risk of hypopituitarism in patients who recovered
from hemorrhagic fever with renal syndrome. J Clin Endocrinol
Metab. 93:2722–2728. 2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Miettinen MH, Mäkelä SM, Ala-Houhala IO,
Huhtala HS, Kööbi T, Vaheri AI, Pasternack AI, Pörsti IH and
Mustonen JT: Ten-year prognosis of Puumala hantavirus-induced acute
interstitial nephritis. Kidney Int. 69:2043–2048. 2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mäkelä S, Jaatinen P, Miettinen M, Salmi
J, Ala-Houhala I, Huhtala H, Hurme M, Pörsti I, Vaheri A and
Mustonen J: Hormonal deficiencies during and after Puumala
hantavirus infection. Eur J Clin Microbiol Infect Dis. 29:705–713.
2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Miettinen M, Mäkelä S, Haapala M,
Helanterä A, Helin H, Vänttinen T and Mustonen J:
Glomerulonephritis emerging shortly after Puumala hantavirus
infection: A report on 7 patients. Clin Nephrol. 75:550–556.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
41
|
Tulumovic D, Imamovic G, Mesic E, Hukic M,
Tulumovic A, Imamovic A and Zerem E: Comparison of the effects of
Puumala and Dobrava viruses on early and long-term renal outcomes
in patients with haemorrhagic fever with renal syndrome. Nephrology
(Carlton). 15:340–343. 2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Mustonen J, Mäkelä S, Helin H, Helanterä
A, Miettinen M, Partanen J and Pasternack A: Mesangiocapillary
glomerulonephritis caused by Puumala hantavirus infection. Nephron.
89:402–407. 2001.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Satoskar A and Tibor Nadasdy TFS: Acute
postinfectious glomerulonephritis and glomerulonephritis caused by
persistent bacterial infection. In: Heptinstall's Pathology of the
Kidney. Jannette JC, Olson JL and Silva FG (eds). 7th edition.
Lippincott Williams & Wilkins, Philadelphia, PA, pp678-798,
2014.
|
|
44
|
Huggins JW: Prospects for treatment of
viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral
drug. Rev Infect Dis. 11 (Suppl 4):S750–S761. 1989.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Huggins JW, Hsiang CM, Cosgriff TM, Guang
MY, Smith JI, Wu ZO, LeDuc JW, Zheng ZM, Meegan JM, Wang QN, et al:
Prospective, double-blind, concurrent, placebo-controlled clinical
trial of intravenous ribavirin therapy of hemorrhagic fever with
renal syndrome. J Infect Dis. 164:1119–1127. 1991.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Rusnak JM, Byrne WR, Chung KN, Gibbs PH,
Kim TT, Boudreau EF, Cosgriff T, Pittman P, Kim KY, Erlichman MS,
et al: Experience with intravenous ribavirin in the treatment of
hemorrhagic fever with renal syndrome in Korea. Antiviral Res.
81:68–76. 2009.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Vial PA, Valdivieso F, Ferres M, Riquelme
R, Rioseco ML, Calvo M, Castillo C, Díaz R, Scholz L, Cuiza A, et
al: High-dose intravenous methylprednisolone for hantavirus
cardiopulmonary syndrome in Chile: A double-blind, randomized
controlled clinical trial. Clin Infect Dis. 57:943–951.
2013.PubMed/NCBI View Article : Google Scholar
|
